u/Comfortable_Job_9262

Reddit r/ValueInvesting
· tracked since Feb 2026
Calls
1
Win Rate
0.0%
return
-14.5%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 1 Short 0
Win Rate
7d 0%
30d 0%
90d 0%
Average Return -14.5% Long Return -14.5% Short Return -
Average Return
7d -3.1%
30d -23.0%
90d -12.5%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
NVO 1ST Novo Nordisk A/S Novo Nordisk A/S
Long
Feb 03
$50.71
-14.5%
Wegovy Brazil filing good for NVO
Author argues Novo Nordisk's submission of the Wegovy pill for approval in Brazil is good news for NVO investors, citing rapidly rising obesity in Brazil (over 60% overweight, obesity doubling from 2006 to 2024) as a key market driver. The mechanism is expanded LatAm access to the obesity franchise, supported by Novo's $1B investment expanding the Montes Carlos facility. Catalyst is the Brazilian regulatory approval; no explicit risk stated beyond 'if everything goes well'.
GLP-1 / Obesity
REDDIT
Showing 1 of 1 calls · sorted by mentions

u/Comfortable_Job_9262 has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: NVO.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology